English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51774889    線上人數 :  1047
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"pei jer chen"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 411-435 / 883 (共36頁)
<< < 12 13 14 15 16 17 18 19 20 21 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-07-03T03:34:41Z A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients Yang T.-S.; Lu S.-N.; Chao Y.; Sheen I.-S.; Lin C.-C.; Wang T.-E.; Chen S.-C.; Wang J.-H.; Liao L.-Y.; Thomson J.A.; Wang-Peng J.; PEI-JER CHEN; Chen L.-T.
臺大學術典藏 2021-07-03T03:34:41Z Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:40Z Eastern asian expert panel opinion: Designing clinical trials of molecular targeted therapy for hepatocellular carcinoma Yeo W.; PEI-JER CHEN; Furuse J.; Han K.-H.; Hsu C.; Lim H.-Y.; Moon H.; Qin S.; Yeoh E.-M.; Ye S.-L.
臺大學術典藏 2021-07-03T03:34:40Z Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf Chen K.-F.; Tai W.-T.; Huang J.-W.; Hsu C.-Y.; Chen W.-L.; Cheng A.-L.; PEI-JER CHEN; Shiau C.-W.
臺大學術典藏 2021-07-03T03:34:40Z CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells Chen K.-F.; Liu C.-Y.; Lin Y.-C.; Yu H.-C.; Liu T.-H.; Hou D.-R.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:40Z Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3 Chen K.-F.; Tai W.-T.; Liu T.-H.; Huang H.-P.; Lin Y.-C.; Shiau C.-W.; Li P.-K.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:39Z Establishment of a knock-in mouse model with the SLC26A4 c.919-2a>G mutation and characterization of its pathology Lu Y.-C.; Wu C.-C.; Shen W.-S.; Yang T.-H.; Yeh T.-H.; PEI-JER CHEN; Yu I.-S.; Lin S.-W.; Wong J.-M.; Chang Q.; Lin X.; Hsu C.-J.
臺大學術典藏 2021-07-03T03:34:39Z Role of microRNAs in hepatitis B virus replication and pathogenesis Liu W.-H.; Yeh S.-H.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:39Z DNA detection using commercial mobile phones Lee D.; Chou W.P.; Yeh S.H.; PEI-JER CHEN; Chen P.H.
臺大學術典藏 2021-07-03T03:34:39Z Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses Yeh M.-L.; Hung C.-H.; Huang J.-F.; Liu C.-J.; Lee C.-M.; Dai C.-Y.; Wang J.-H.; Lin Z.-Y.; Lu S.-N.; Hu T.-H.; Yu M.-L.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:38Z Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan Mah Y.-H.; Hsu C.-S.; Liu C.-H.; Liu C.-J.; Lai M.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:38Z Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A Chen K.-F.; Yu H.-C.; Liu C.-Y.; Chen H.-J.; Chen Y.-C.; Hou D.-R.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:38Z Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells Chen K.-F.; Chen H.-L.; Tai W.-T.; Feng W.-C.; Hsu C.-H.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:38Z Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy Tseng T.-C.; Yu M.-L.; Liu C.-J.; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; Liu C.-H.; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:37Z Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinoma Shao Y.U.-Y.; PEI-JER CHEN; Lin Z.-Z.; Huang C.-C.; Ding Y.-H.; Lee Y.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:37Z Hepatitis B viraemia: Its heritability and association with common genetic variation in the interferon γ signalling pathway Huang H.-H.; Shih W.-L.; Li Y.-H.; Wu C.-F.; PEI-JER CHEN; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Yu M.-W.
臺大學術典藏 2021-07-03T03:34:37Z Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters Tseng T.; Liu C.; Su T.; Wang C.; Chen C.; PEI-JER CHEN; Chen D.; Kao J.
臺大學術典藏 2021-07-03T03:34:37Z Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): Development and validation of a predictive score Yang H.-I.; Yuen M.-F.; Chan H.L.Y.; Han K.-H.; PEI-JER CHEN; Kim D.-Y.; Ahn S.-H.; Chen C.-J.; Wong V.W.S.; Seto W.-K.
臺大學術典藏 2021-07-03T03:34:36Z Hepatitis B and Deltavirus Infections Chen D.-S.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:36Z The clinical significance of occult hepatitis B transfusion in Taiwan - a look-back study Su T.-H.; PEI-JER CHEN; Chen T.-C.; Cheng H.-R.; Li L.; Lin K.-S.; Kao J.-H.; Chen D.-S.; Liu C.-J.
臺大學術典藏 2021-07-03T03:34:36Z Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients Liu C.-H.; Liang C.-C.; Huang K.-W.; Liu C.-J.; Chen S.-I.; Lin J.-W.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; PEI-JER CHEN; Chen J.-H.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:36Z HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection Hsu S.-J.; Hsu C.-S.; Liu C.-H.; Liu C.-J.; Chen C.-L.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:35Z Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Tseng T.-C.; Liu C.-H.; Niu W.-F.; Jeng J.; Liu C.-J.; Lai M.-Y.; PEI-JER CHEN; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:35Z Rapid DNA amplification in a capillary tube by natural convection with a single isothermal heater Chou W.P.; Chen P.H.; Miao Jr. M.; Kuo L.S.; Yeh S.H.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:35Z Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN; Chen K.-F.

顯示項目 411-435 / 883 (共36頁)
<< < 12 13 14 15 16 17 18 19 20 21 > >>
每頁顯示[10|25|50]項目